14C-d-xylose and lactulose breath tests, endotoxin levels, intestinal permeability, tumour necrosis factor α (TNF-α) levels, small intestinal transit time, and diabetes prevalence in patients with non-alcoholic steatohepatitis (NASH)
| Patient No | 14C-d-xylose + lactulose breath test | Endotoxin level (EU/ml) | Intestinal permeability (L/R ratio) | TNF-α (pg/ml) | Small intestinal transit time (minutes) | Diabetes (yes/no/gi) |
|---|---|---|---|---|---|---|
| 1 | Positive | 1.0 | 5.8 | 180 | No | |
| 2 | Negative | 1.2 | 0.13 | 6.6 | No | |
| 3 | Positive | 0.9 | 0.19 | 27 | 240 | gi |
| 4 | Negative | 1.0 | 0.06 | 14.3 | 180 | gi |
| 5 | Positive | 1.4 | 0.33 | 10.8 | 150 | No |
| 6 | Negative | 1.2 | 22.3 | No | ||
| 7 | Negative | 0.9 | 0.09 | 5.4 | gi | |
| 8 | Negative | 1.0 | 0.05 | 14.3 | No | |
| 9 | Positive | 0.7 | 0.5 | 20 | 210 | Yes |
| 10 | Positive | 0.8 | 8.9 | 210 | No | |
| 11 | Negative | 1.2 | 0.36 | 18.9 | 210 | No |
| 12 | Positive | 0.9 | 0.10 | 7.3 | 210 | gi |
| 13 | Negative | 1.5 | 0.05 | 20.8 | 120 | No |
| 14 | Positive | 3.5 | 0.13 | 210 | No | |
| 15 | Negative | 1.6 | 0.29 | 4.7 | 120 | No |
| 16 | Positive | 1.2 | 0.49 | 32.3 | 180 | No |
| 17 | Negative | 0.9 | 13.5 | 120 | No | |
| 18 | Negative | 1.6 | 0.9 | 3.5 | Yes | |
| 19 | Negative | 1.3 | 0.05 | 11.6 | Yes | |
| 20 | Positive | 1.2 | 0.1 | 20.4 | 240 | Yes |
| 21 | Positive | 0.9 | 0.09 | 17.3 | 120 | No |
| 22 | Positive | 1.0 | 0.25 | 3.9 | 210 | Yes |
| Mean (SD) | 1.2 (0.6) | 0.16 (0.13) | 14.2 (8.1) | 182 (43) |
gi, glucose intolerance.